Ethical approval
We obtained imformed consent from the patient’s husband.
Author contributions
AN, T Takezaki, TK, YY, S Kurosawa, S Kaito, K Yoshifuji, KH, MS, SY, K Yoshioka, T Toya, and KI contributed to the clinical care of the patient. AI, YN, HM, ND, TK, KK, HH, HS, and KO assessed the clinical course and discussed the treatment for the patient. YH analyzed sequencing of leukemic cells. KO supervised the project. AN and ND wrote the manuscript.
Disclosure statement
No potential conflict of interest was reported by the author(s).